The OJC 55: The Gut Microbiota, Electronic Health Records and COVID Risks

11/18/21 • 39 min

The Oncology Journal Club - Delivering Oncology News Differently
The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 55 in our series The Oncology Journal Club.
Welcome to this week's episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers.
This week Eva talks us through a paper which will be very helpful for current practice. It looks at risk prediction of COVID-19 related deaths and hospital admissions in adults after vaccination.

Hans buried himself in Science and Cell papers this week for his main paper and quick bites. All are focused on the microbiome, the role of bacteria and following an elemental diet. Fascinating stuff!

And Craig brings us back down to the ground with a practice changing paper. He looks at oncology patients' perception of physicians who use an integrated electronic health record during clinic visits.
You’ll also find out key trends in drug revenue among major pharmaceutical companies, how a geriatric assessment–driven intervention reduced chemotherapy-related toxic effects in older adults and why the day of the week you submit effects publication rates in peer reviewed journals.
In ‘The Paper That Changed My Practice’ segment we hear from our friend Nathan Cherny with a beautifully poignant paper.

Full bios and the list of all papers discussed are available on our website.For the latest oncology news visit www.oncologynews.com.au and for regular oncology updates for healthcare professionals, subscribe for free to get the weekly The Oncology Newsletter.
The Oncology Podcast - An Australian Oncology Perspective

Send us a text

Previous Episode

Theranostics and Neuroendocrine Tumours: Where do we go next?

Send us a text

The Oncology Podcast - Delivering Oncology News Differently

Welcome to episode 6 in ourExperts On Point podcast series brought to you from The Oncology Podcast .
Today's podcast explores the role of theranostics in neuroendocrine tumours - in celebration of World NET Cancer Day on the 10th November 2021.
Rachael Babin chats to Simone Leydon and Aviral Singh about the future of theranostics in Australia.

Simone Leyden is CEO, and Co-Founder of NeuroEndocrine Cancer Australia. Dr Aviral Singh who is a Specialist Nuclear Medicine Physician from Germany and Clinical Research and Development Manager for GenesisCare. He practices Theranostics for the management of Neuroendocrine Neoplasms and Prostate Cancer.
We hope you enjoy today's episode.
For news and podcast updates subscribe to the The Oncology Newsletter, a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.
PART OF THE ONCOLOGY NETWORK

Next Episode

The OJC 56: Is food the future of cancer treatment?

Send us a text

The Oncology Journal Club - Delivering Oncology News Differently
The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 56 in our series The Oncology Journal Club.
Welcome to this week's episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers.
Is food the future of cancer treatment? Hans thinks so! This week he presents Nature papers focused on diet.

Eva talks us through breast cancer patients with low hormone receptor positivity. And Craig presents the Dutch PLASTIC study provoking a great discussion around PET scans for staging locally advanced gastric cancer.

You’ll also find out links between immune checkpoint inhibitors and decreased incidence of second primary cancers. And the Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms. And Eva talks us through a great exercise paper from our friend Matthew Katz.

In ‘The Paper That Changed My practice’ segment – we hear from Mark Nalder, a young medical oncologist from Queensland.